Literature DB >> 6802538

Reactive and neoplastic human lymphoid cells producing J chain in the absence of immunoglobulin: evidence for the existence of 'J chain disease'?

D Y Mason, H Stein.   

Abstract

The initiation of cytoplasmic Ig synthesis in differentiating B cells is accompanied by the start of cytoplasmic J chain production. As the cell matures further, J chain synthesis ceases (unless it is producing dimeric IgA or 19S IgM). In consequence, it is common to find Ig-positive, J chain-negative cells in reactive lymphoid tissue. However, the reverse pattern (Ig-negative/J chain-positive), which would indicate J chain production unaccompanied by Ig synthesis, has not been reported. In this paper we describe the detection of such cells in reactive human lymphoid tissue by a double immunoenzymatic labelling technique. Furthermore, retrospective immunohistological analysis of 90 cases of human high-grade lymphoma revealed three cases in which the neoplastic cells appeared to synthesize J chain but not Ig. These findings suggest that the term J chain disease might be introduced to describe this new class of lymphoid neoplasm. However, it is pointed out that immunochemical categories of human B lymphoproliferative diseases based upon patterns of Ig synthesis are often in direct conflict with histological categories (cf. mu chain-producing neoplasms) and the term J chain disease cannot therefore be recommended. It is probable that further cases of J chain-positive, Ig-negative lymphoid neoplasms, covering a range of histological categories, will be described in the future.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6802538      PMCID: PMC1536406     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  24 in total

1.  A new case of heavy mu-chain disease.

Authors:  F Danon; C Mihaesco; M Bouvry; M Clerc; M Seligmann
Journal:  Scand J Haematol       Date:  1975-08

Review 2.  Heavy chain diseases: clinical features and molecular significance of the disordered immunoglobulin structure.

Authors:  B Frangione; E C Franklin
Journal:  Semin Hematol       Date:  1973-01       Impact factor: 3.851

3.  Characterization of the J chain from polymeric immunoglobulins (IgA-IgM-immunological specificity-primary structure).

Authors:  S L Morrison; M E Koshland
Journal:  Proc Natl Acad Sci U S A       Date:  1972-01       Impact factor: 11.205

4.  Noval subunit in secretory IgA.

Authors:  M S Halpern; M E Koshland
Journal:  Nature       Date:  1970-12-26       Impact factor: 49.962

5.  Biosynthesis and assembly of IgM. Addition of J chain to intracellular pools of 8S and 19S IgM.

Authors:  D I Stott
Journal:  Immunochemistry       Date:  1976-02

6.  Does J chain mediate the combination of 19S IgM and dimeric IgA with the secretory component rather than being necessary for their polymerization?

Authors:  T Eskeland; P Brandtzaeg
Journal:  Immunochemistry       Date:  1974-03

7.  Reassociation of IgM subunits in the presence and absence of J chain.

Authors:  E Kownatzki
Journal:  Immunol Commun       Date:  1973

8.  Presence of J chain in human immunocytes containing various immunoglobulin classes.

Authors:  P Brandtzaeg
Journal:  Nature       Date:  1974-11-29       Impact factor: 49.962

9.  IgM reassociation in Vitro: no influence of J chain on the amount of polymers.

Authors:  T Eskeland
Journal:  Scand J Immunol       Date:  1974       Impact factor: 3.487

10.  Parallel synthesis of immunoglobulins and J chain in pokeweed mitogen-stimulated normal cells and in lymphoblastoid cell lines.

Authors:  J Mestecky; R J Winchester; T Hoffman; H G Kunkel
Journal:  J Exp Med       Date:  1977-03-01       Impact factor: 14.307

View more
  10 in total

1.  Precursor B cells transformed by Epstein-Barr virus undergo sterile plasma-cell differentiation: J-chain expression without immunoglobulin.

Authors:  H Kubagawa; P D Burrows; C E Grossi; J Mestecky; M D Cooper
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

2.  Primary mediastinal clear cell lymphoma of B-cell type.

Authors:  P Möller; B Lämmler; M Eberlein-Gonska; G E Feichter; W J Hofmann; H Schmitteckert; H F Otto
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1986

3.  Immunophenotyping of non-Hodgkin's lymphoma. Lack of correlation between immunophenotype and cell morphology.

Authors:  H J Schuurman; J van Baarlen; W Huppes; B W Lam; L F Verdonck; J A van Unnik
Journal:  Am J Pathol       Date:  1987-10       Impact factor: 4.307

4.  Two-colour immunoenzymatic technique using sequential staining by APAAP to evaluate two cell antigens.

Authors:  R Burgess; K Hyde; P J Maguire; P R Kelsey; J A Yin; C G Geary
Journal:  J Clin Pathol       Date:  1992-03       Impact factor: 3.411

5.  J-chain-producing immunoblastic lymphoma in a case of Richter's syndrome. Immunohistochemical evidence for a gradual malignant transformation of a single B-cell clone and flow cytophotometric data.

Authors:  P Möller; G E Feichter; D Fritze; D Haag; B Schüle
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1982

6.  Evaluation of tissue preparation methods and paired immunofluorescence staining for immunocytochemistry of lymphomas.

Authors:  P Brandtzaeg; T O Rognum
Journal:  Histochem J       Date:  1983-07

7.  Intracellular J chains in lymphoproliferative diseases.

Authors:  G Kelényi
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1985

8.  Paired indirect immunoenzyme staining with primary antibodies from the same species. Application of horseradish peroxidase and alkaline phosphatase as sequential labels.

Authors:  K Valnes; P Brandtzaeg
Journal:  Histochem J       Date:  1984-05

9.  Human J chain gene. Structure and expression in B lymphoid cells.

Authors:  E E Max; S J Korsmeyer
Journal:  J Exp Med       Date:  1985-04-01       Impact factor: 14.307

10.  Ultrastructural studies of human lymphoid cells. mu and J chain expression as a function of B cell differentiation.

Authors:  I Hajdu; Z Moldoveanu; M D Cooper; J Mestecky
Journal:  J Exp Med       Date:  1983-12-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.